Paul Helbling

CEO @ Dualsystems Biotech | Drug Discovery Target Identification on living cells

Zurich, Switzerland

About

At Dualsystems Biotech we identify targets of peptides, proteins, viruses at the cell surface of living cells (primary cells or cell lines) without the need to genetically modify the cells or a hypothesis what the target might be. We have identified novel drug targets for many different disease indications (novel drug targtes against cancer, asthma, metabolic diseases and more) since the cell surface is crucial for the cell communication and therefore a very good target for drug treatments.

Experience

  • Dualsystems Biotech (12 yrs 9 mos)
    • CEO
      Feb 2015 - Present · 11 yrs 5 mos

    • Head of Business Development, Marketing and Sales
      Oct 2013 - Jan 2015 · 1 yr 4 mos

      Fully responsible for Dualsystems Biotech AG. Reporting directly to the supervisory board. Dualsystems is a proteomics service provider specialized in elucidating protein-protein interactions. Especially, identification of cell membrane receptors for peptides/proteins/antibodies/viruses on the living cell (cell lines, primary cells) and on tissue without genetic manipulation.

  • Chairman of the Board at Wildlife Hospitality AG with the Emhosheni River Lodge
    Dec 2024 - Present · 1 yr 7 mos

  • Head of International Business Development at IBR Inc
    Apr 2011 - Sep 2013 · 2 yrs 6 mos

    Work according to GLP

  • Business Development Manager at Solvias AG
    Sep 2008 - Feb 2011 · 2 yrs 6 mos

    Work according to GMP

  • Project Manager / BPI / Customer Manger/ Lab Head Ligand Binding at MDS Pharma Services
    2002 - 2008 · 6 yrs

    Work according to GLP